Resverlogix Corp. Stock OTC Markets
Stocks
RVXCF
CA76128M1086
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
21:49:46 01/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0622 USD | -8.47% |
|
+3.67% | -16.17% |
| Market Cap | 21.74M 15.26M 13.55M 12.67M 11.55M 1.47B 22.04M 153M 59.36M 748M 57.29M 56.05M 2.4B | P/E 2024 |
-1.38x | P/E 2025 | -2.68x |
|---|---|---|---|---|---|
| Enterprise Value | 108M 75.46M 67.03M 62.68M 57.12M 7.27B 109M 758M 294M 3.7B 283M 277M 11.88B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
60.44% | Yield 2024 * |
-
| Yield 2025 | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| RVX | Delayed | |
London S.E.
| 0VF9 | Delayed | |
|
OTC Markets
| RVXCF | Delayed | |
|
Deutsche Boerse AG
| RFS | Delayed | |
|
Börse Stuttgart
| RFS | Delayed |
Last Transcript: Resverlogix Corp.
| 1 day | -8.47% | ||
| 1 week | +3.67% | ||
| Current month | -8.53% | ||
| 1 month | -12.57% | ||
| 3 months | +3.32% | ||
| 6 months | -20.61% | ||
| Current year | -16.17% |
| 1 week | 0.06 |  | 0.07 |
| 1 month | 0.06 | | 0.07 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.05 | | 0.1 |
| 3 years | 0.02 | | 0.21 |
| 5 years | 0.02 | | 0.65 |
| 10 years | 0.02 | | 4.14 |
| Manager | Title | Age | Since |
|---|---|---|---|
Donald McCaffrey
CEO | Chief Executive Officer | - | 25/04/2003 |
Anthony Cann
DFI | Director of Finance/CFO | 78 | 29/10/2009 |
| Chief Tech/Sci/R&D Officer | - | 15/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Donald McCaffrey
CHM | Chairman | - | 04/04/2016 |
Kelly McNeill
BRD | Director/Board Member | 56 | 15/10/2009 |
Kenneth Zuerblis
BRD | Director/Board Member | 66 | 29/09/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.47% | +3.67% | - | - | 21.74M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -2.78% | -3.34% | +22.16% | +74.95% | 59.26B | |
| +1.28% | -0.21% | +4.72% | +35.08% | 47.14B | |
| +0.30% | -5.20% | +27.94% | +32.51% | 42.91B | |
| +0.35% | +3.02% | +348.95% | +643.82% | 44.13B | |
| -2.02% | -0.33% | +7.04% | +99.46% | 40.79B | |
| +3.32% | +3.49% | +10.10% | +51.23% | 30.77B | |
| -2.68% | +2.92% | +29.63% | +22.72% | 29.31B | |
| -1.81% | -10.66% | -26.27% | +330.06% | 23.71B | |
| Average | -0.79% | -0.52% | +52.63% | +153.78% | 43.6B | |
| Weighted average by Cap. | +0.36% | -0.32% | +57.72% | +145.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -7.64M -5.36M -4.76M -4.45M -4.06M -516M -7.74M -53.84M -20.84M -263M -20.12M -19.68M -844M | -7.77M -5.45M -4.84M -4.53M -4.13M -525M -7.87M -54.77M -21.2M -267M -20.46M -20.02M -858M |
| Net Debt | 81.87M 57.45M 51.03M 47.72M 43.49M 5.53B 83M 577M 223M 2.82B 216M 211M 9.05B | 85.79M 60.2M 53.47M 50.01M 45.57M 5.8B 86.97M 605M 234M 2.95B 226M 221M 9.48B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | $0.0622 | -8.47% | 3,133 |
| 30/09/26 | $0.0680 | -1.88% | 1,000 |
| 25/09/26 | $0.0693 | +15.50% | 610 |
| 24/09/26 | $0.0600 | -6.54% | 40,000 |
| 23/09/26 | $0.0642 | +1.26% | 23,000 |
- Stock Market
- Stocks
- RVX Stock
- RVXCF Stock
Select your edition
All financial news and data tailored to specific country editions
